{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:17:49Z","timestamp":1768292269150,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.adro.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,7,17]],"date-time":"2016-07-17T01:27:07Z","timestamp":1468718827000},"page":"230-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Chemoradiation therapy with docetaxel in elderly patients with stage II\/III esophageal cancer: A phase 2 trial"],"prefix":"10.1016","volume":"1","author":[{"given":"Akihiro","family":"Ohba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikatoshi","family":"Katada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehiro","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2016.07.002_bib1","first-page":"74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.adro.2016.07.002_bib2","unstructured":"The Editorial Board of the Cancer Statistics in Japan. Cancer Statistics in Japan 2007 Foundation for Promotion of Cancer Research."},{"key":"10.1016\/j.adro.2016.07.002_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1442-2050.2003.00300.x","article-title":"Clinical outcome and survival after esophagectomy for carcinoma in elderly patients","volume":"16","author":"Bonavina","year":"2003","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.adro.2016.07.002_bib4","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1200\/JCO.2006.09.7931","article-title":"Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: A population-based analysis of elderly patients","volume":"25","author":"Steyerberg","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.07.002_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0003-4975(00)02333-X","article-title":"Esophageal resection in elderly esophageal carcinoma patients: Improvement in postoperative complications","volume":"71","author":"Kinugasa","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.adro.2016.07.002_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF02557376","article-title":"Esophageal resection for carcinoma in patients older than 70 years","volume":"9","author":"Sabel","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2016.07.002_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/01.sla.0000143123.24556.1c","article-title":"Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer","volume":"240","author":"Law","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.adro.2016.07.002_bib8","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.adro.2016.07.002_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1442-2050.2009.01014.x","article-title":"Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older","volume":"23","author":"Mak","year":"2010","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.adro.2016.07.002_bib10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/sj.bjc.6603821","article-title":"Combined modality chemoradiation in elderly oesophageal cancer patients","volume":"96","author":"Anderson","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.adro.2016.07.002_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000351617","article-title":"Erlotinib and radiation therapy for elderly patients with esophageal cancer - clinical and correlative results from a prospective multicenter phase 2 trial","volume":"85","author":"Iyer","year":"2013","journal-title":"Oncology"},{"key":"10.1016\/j.adro.2016.07.002_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02993858","article-title":"Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: The Eastern Cooperative Oncology Group (ECOG) results of protocol E1293","volume":"13","author":"Einzig","year":"1996","journal-title":"Med Oncol"},{"key":"10.1016\/j.adro.2016.07.002_bib13","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1053\/j.seminoncol.2005.04.005","article-title":"Docetaxel in the treatment of esophageal cancer","volume":"32","author":"Rigas","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1016\/j.adro.2016.07.002_bib14","first-page":"1842","article-title":"Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells","volume":"56","author":"Hennequin","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.adro.2016.07.002_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3727\/0965040041791455","article-title":"Radiosensitization of colon cancer cell lines by docetaxel: Mechanisms of action","volume":"14","author":"Dunne","year":"2004","journal-title":"Oncol Res"},{"key":"10.1016\/j.adro.2016.07.002_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1200\/JCO.1998.16.1.159","article-title":"Phase I study of docetaxel with concomitant thoracic radiation therapy","volume":"16","author":"Mauer","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.07.002_bib17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0959-8049(97)10101-0","article-title":"Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I\/II dose escalation trial","volume":"34","author":"Koukourakis","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2016.07.002_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0360-3016(03)01370-1","article-title":"Radiotherapy with concomitant weekly docetaxel for stages III\/IV oropharynx carcinoma. Results of the 98-02 GORTEC phase II trial","volume":"58","author":"Calais","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2016.07.002_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10147-003-0375-z","article-title":"Phase I\/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck","volume":"9","author":"Fujii","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.adro.2016.07.002_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2016.07.002_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10388-008-0151-2","article-title":"Guidelines for diagnosis and treatment of carcinoma of the esophagus; April 2007 edition: Part I. Edited by the Japan Esophageal Society","volume":"5","author":"Kuwano","year":"2008","journal-title":"Esophagus"},{"key":"10.1016\/j.adro.2016.07.002_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijrobp.2010.06.033","article-title":"Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906)","volume":"81","author":"Kato","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2016.07.002_bib23","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2016.07.002_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/COC.0b013e3180ca7c84","article-title":"A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer","volume":"30","author":"Takeuchi","year":"2007","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.adro.2016.07.002_bib25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.07.002_bib26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ijrobp.2014.03.030","article-title":"Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: A phase 2 trial (KDOG 0501-P2)","volume":"89","author":"Higuchi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109416300331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109416300331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:35:00Z","timestamp":1762529700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109416300331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2452109416300331"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2016.07.002","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemoradiation therapy with docetaxel in elderly patients with stage II\/III esophageal cancer: A phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}